Thijs Hendrikx

61 total papers · 2.7k total citations
49 papers, 2.1k citations indexed

About

Thijs Hendrikx is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Thijs Hendrikx has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 23 papers in Hematology and 18 papers in Immunology. Recurrent topics in Thijs Hendrikx's work include Rheumatoid Arthritis Research and Therapies (38 papers), Spondyloarthritis Studies and Treatments (26 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Thijs Hendrikx is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (38 papers), Spondyloarthritis Studies and Treatments (26 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Thijs Hendrikx collaborates with scholars based in United States, Canada and Netherlands. Thijs Hendrikx's co-authors include Keith S. Kanik, Sujatha Menon, Désirée van der Heijde, Cunshan Wang, Philip J. Mease, Carla C. Baan, Dafna D. Gladman, Elizabeth M. Kudlacz, Daniela Graham and Oliver FitzGerald and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of the Rheumatic Diseases.

In The Last Decade

Thijs Hendrikx

49 papers receiving 2.1k citations

Hit Papers

Tofacitinib or Adalimumab... 2017 2026 2020 2023 2017 2017 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
    2017 419 citations Philip J. Mease, Stephen Hall et al. New England Journal of Medicine profile →
  2. Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
    2017 377 citations Dafna D. Gladman, William F. C. Rigby et al. New England Journal of Medicine profile →
  3. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
    2017 273 citations Désirée van der Heijde, Atul Deodhar et al. Annals of the Rheumatic Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thijs Hendrikx 1.5k 1.2k 879 284 140 49 2.1k
Raymond E. Felgar 811 0.5× 1.4k 1.1× 270 0.3× 485 1.7× 377 2.7× 38 2.8k
A. J. G. Swaak 1.6k 1.1× 1.2k 1.0× 297 0.3× 121 0.4× 101 0.7× 69 2.5k
Marie Audrain 383 0.3× 827 0.7× 217 0.2× 456 1.6× 54 0.4× 62 1.7k
Capucine Daridon 649 0.4× 1.1k 0.9× 161 0.2× 207 0.7× 56 0.4× 35 2.2k
Ann Traynor 432 0.3× 582 0.5× 680 0.8× 402 1.4× 97 0.7× 63 2.1k
Valérie Devauchelle 874 0.6× 876 0.7× 181 0.2× 313 1.1× 54 0.4× 57 2.2k
A Marmont 215 0.1× 905 0.8× 1.5k 1.7× 458 1.6× 28 0.2× 43 2.1k
Fabien B. Vincent 778 0.5× 1.2k 1.0× 153 0.2× 196 0.7× 51 0.4× 33 1.8k
Annett M. Jacobi 1.4k 1.0× 2.2k 1.9× 143 0.2× 246 0.9× 35 0.3× 44 3.0k
William Shergy 1.2k 0.8× 559 0.5× 484 0.6× 213 0.8× 20 0.1× 24 1.9k

Countries citing papers authored by Thijs Hendrikx

Since Specialization
Citations

This map shows the geographic impact of Thijs Hendrikx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thijs Hendrikx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thijs Hendrikx more than expected).

Fields of papers citing papers by Thijs Hendrikx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thijs Hendrikx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thijs Hendrikx. The network helps show where Thijs Hendrikx may publish in the future.

Co-authorship network of co-authors of Thijs Hendrikx

This figure shows the co-authorship network connecting the top 25 collaborators of Thijs Hendrikx. A scholar is included among the top collaborators of Thijs Hendrikx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thijs Hendrikx. Thijs Hendrikx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lori Armstrong Breakdown of academic impact, for papers by G.S.P. Groot Breakdown of academic impact, for papers by Angela M. Mitchell Breakdown of academic impact, for papers by Jiao Hu Breakdown of academic impact, for papers by Lauren I. R. Ehrlich Breakdown of academic impact, for papers by Maha Alafeef Breakdown of academic impact, for papers by Anja Fromm Breakdown of academic impact, for papers by Jérôme Molénat
Rankless by CCL
2026